MedTrace Logo

Feasibility Evaluation - Blood Glucose Level Monitoring by Microwave Metamaterial Sensor in Blood Samples.

NCT05929196 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2024-02-28

No results posted yet for this study

Summary

The goal of this clinical trial is to test microwave metamaterial glucose sensor on blood samples. It means to compare the results of glucose values obtained by microwave metamaterial sensor and by standard biochemical analyzer.

Conditions

Interventions

DIAGNOSTIC_TEST

In vitro full blood diagnostic test.

Participant will donate approximately 5 ml blood sample. Later in a laboratory the sample will be processed in the microwave metamaterial sensor for non invasive blood glucose monitoring and standard biochemical analyzer. Specific dielectric properties and scattering parameters will be measured for blood glucose level determination.

Sponsors & Collaborators

  • Czech Technical University in Prague

    lead OTHER

Principal Investigators

  • Luděk Šprongl, Ing. · Regional hospital in Kladno

  • Lukáš Malena, Ing. · Czech Technical University in Prague

  • David Vrba, doc. · Czech Technical University in Prague

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-07-12
Primary Completion
2023-07-17
Completion
2023-09-01

Countries

  • Czechia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05929196 on ClinicalTrials.gov